Peeling skin syndrome: genetic defects in late terminal differentiation of the epidermis

J Invest Dermatol. 2011 Mar;131(3):561-4. doi: 10.1038/jid.2010.434.

Abstract

In this issue, Israeli and colleagues confirm that homozygous mutations in corneodesmosin (CDSN) cause type B peeling skin syndrome (PSS), an autosomal recessive skin disorder. The deletion mutation described resulted in a frameshift, producing a downstream premature stop codon and early truncation of the protein. The recently described CDSN nonsense mutation in another PSS family also resulted in protein truncation and nonsense-mediated mRNA decay. Type B generalized PSS can now be clearly distinguished from acral PSS, caused by mutations in transglutaminase 5. This directly affects cornified envelope cross-linking rather than corneodesmosome adherence. These observations provide new insight into the molecular defects underlying two closely related forms of PSS.

Publication types

  • Comment

MeSH terms

  • Dermatitis, Exfoliative / diagnosis
  • Dermatitis, Exfoliative / genetics*
  • Diagnosis, Differential
  • Glycoproteins / genetics*
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Mutation, Missense / genetics*
  • Pigmentation Disorders / diagnosis
  • Pigmentation Disorders / genetics
  • Skin Diseases / congenital
  • Transglutaminases / genetics

Substances

  • CDSN protein, human
  • Glycoproteins
  • Intercellular Signaling Peptides and Proteins
  • transglutaminase 5
  • Transglutaminases

Supplementary concepts

  • Peeling skin syndrome, acral type